Aquatic Proteins Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 23.32 Cr
as on 19-12-2024
- Company Age 10 Year,
- Last Filing with ROC 31 Mar 2024
- Revenue -31.46%
(FY 2020)
- Profit -31.47%
(FY 2020)
- Ebitda
- Net Worth
- Total Assets 0.03%
(FY 2020)
About Aquatic Proteins
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 23.32 Cr, as per Ministry of Corporate Affairs (MCA) records.
Abraham Tharakan, Keya Tharakan, Robert Maxime, and Five other members serve as directors at the Company.
- CIN/LLPIN
U15490KL2015FTC037810
- Company No.
037810
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
14 Jan 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aquatic Proteins?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipak Chummun  | Director | 18-May-2015 | Current |
Abraham Tharakan  | Director | 14-Jan-2015 | Current |
| Keya Tharakan | Director | 18-May-2015 | Current |
| Robert Maxime | Director | 18-May-2015 | Current |
| Gopalakrishna Purseramen | Director | 18-May-2015 | Current |
Yann Duchesne  | Nominee Director | 30-Jun-2016 | Current |
Financial Performance of Aquatic Proteins.
Aquatic Proteins Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 31.46% decrease. The company also saw a substantial fall in profitability, with a 31.47% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aquatic Proteins?
In 2018, Aquatic Proteins had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Viceregal Travels And Resorts LimitedActive 31 years 11 monthsAbraham Tharakan and Keya Tharakan are mutual person
Amalgam Nutrients & Feeds LimitedActive 36 years 8 monthsAbraham Tharakan and Keya Tharakan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aquatic Proteins?
Unlock and access historical data on people associated with Aquatic Proteins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aquatic Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquatic Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
